Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies

Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications.

ADA 2024: Altimmune’s GLP-1 drug shows weight loss potential – Pharmaceutical Technology

At the ADA scientific sessions, Altimmune presented data demonstrating significant weight loss in patients who took pemvidutide. Credit: Pavel Kapysh via Shutterstock. Altimmune has taken

June 24, 2024

New method developed for triggering and imaging seizures in epilepsy patients

Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy

March 12, 2024

Opinion | Let’s Fix Maintenance of Certification

N. Adam Brown is a practicing emergency physician, entrepreneur, and healthcare executive. He is the founder of ABIG Health, a healthcare growth strategy firm, and

April 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.